← Leaderboards
Lisa M Deangelis
Sloan-Kettering Institute For Cancer Res
$810,733
Attributed
$810,733
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $169.6K · FY2005–08$200K$150K$100K$50K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$810,733 · 2
By mechanism
U01$810,733 · 1
P20$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Institute For Cancer Res
Same institution · by research overlap
- Steven M Larson$7,955,537
- Eric C Holland$32,588,073
- John L Humm$4,845,995
- Neal Rosen$21,048,001
- David R Spriggs$13,987,182
Others in their field
Top investigators on “Glioma”
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$158,144,386
- Todd A Alonzo · University Of Colorado Denver/Hsc Denver$72,436,447
- David Heimbrook · Leidos Biomedical Research, Inc.$56,561,099
- Gregory H Reaman · National Childhood Cancer Foundation$49,046,612
- Melissa L Bondy · Stanford University$36,047,564
- Brad H. Pollock · University Of Florida$28,646,726
Research focus
GliomaTissue Resource /RegistryClinical Trial Phase IiNeoplasm /Cancer DiagnosisHuman SubjectClinical TrialsBrain NeoplasmsDrug Delivery SystemsDrug Screening /EvaluationNeoplasm /Cancer ChemotherapyPatient Oriented ResearchDrug Design /Synthesis /ProductionNeoplasm /Cancer Relapse /RecurrenceDrug Discovery /IsolationDisease /Disorder ModelClinical ResearchClinical Trial Phase IClinicChemotherapyBiomedical FacilityCancer Therapy Evaluation ProgramCytotoxic AgentCancer TherapyBiological Response Modifier Therapy
Grant awards (6)
Participating Member Institution in NABTC$169,613
U01 · FY2008 · CA · contact PI
Participating Member Institution in NABTC$169,396
U01 · FY2007 · CA · contact PI
Participating Member Institution in NABTC$161,185
U01 · FY2006 · CA · contact PI
Participating Member Institution in NABTC$157,204
U01 · FY2005 · CA
Participating Member Institution in NABTC$153,335
U01 · FY2004 · CA
Core--Clinical trials$0
P20 · FY2002 · CA